Crossmark Global Holdings’s Pharming Group PHAR Stock Holding History

Crossmark Global Holdings’s Portfolio PHAR Stock Details PHAR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$125K	Hold	12,463	–	–	﹤0.01%	1249
2026 Q2	$169K	Buy	+12,463	New	+$180K	﹤0.01%	1244

Other funds holding PHAR

SBCM

Silverberg Bernstein Capital Management Armonk, New York $211M AUM 58.81% 1-Year Est. Return

Crossmark Global Holdings's PHAR Position: Q3 2026 in Review

Crossmark Global Holdings held its Pharming Group (PHAR) position steady in Q3 2026 at 12,463 shares worth $125K. The position accounts for ﹤0.01% of the portfolio, ranked #1249.

Crossmark Global Holdings first reported a position in PHAR in Q2 2026 and has held it in 2 quarters since. The position peaked at $169K in Q2 2026. 2 funds tracked by Wall St. Rank hold PHAR as of Q3 2026.

Crossmark Global Holdings held 12,463 shares of Pharming Group worth $125K as of Q3 2026.
Crossmark Global Holdings left its Pharming Group share count unchanged in Q3 2026.
Pharming Group made up ﹤0.01% of Crossmark Global Holdings's portfolio in Q3 2026, its #1249 holding.
Crossmark Global Holdings first reported a position in Pharming Group in Q2 2026 and has held it in 2 quarters since.
Crossmark Global Holdings's Pharming Group position peaked at $169K in Q2 2026.
2 funds tracked by Wall St. Rank held Pharming Group as of Q3 2026.

Based on Crossmark Global Holdings's 13F filing for Q3 2026, filed 21 Oct 2026.